Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-12-16

FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Viibryd (vilazodone hydrochloride) from Allergan, Inc., indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)